ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,648Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 973

$1.14M Total Retail Price of All Prescriptions

Rank: 6 out of 973

593 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 593 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

23% of this provider’s 593 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 14,900 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LEVOTHYROXINE SODIUM 859 749 1 2
HYDROCODONE-ACETAMINOPHEN 598 470 S3 2 4
SIMVASTATIN 533 391 3 1
AMLODIPINE BESYLATE 495 458 4 7
LISINOPRIL 480 369 5 3
FUROSEMIDE 455 417 6 6
GABAPENTIN 417 369 7 12
POTASSIUM CHLORIDE 402 394 8 9
WARFARIN SODIUM 358 301 9 10
OMEPRAZOLE 337 274 10 5
CARVEDILOL 289 261 11 27
DONEPEZIL HCL 258 255 12 26
CITALOPRAM HBR 249 195 13 14
ATORVASTATIN CALCIUM 242 184 14 15
QUETIAPINE FUMARATE 227 202 15 70
METOPROLOL TARTRATE 196 182 16 13
FENTANYL 190 185 S2 17 53
SERTRALINE HCL 186 167 18 21
CYMBALTA 182 129 19 40
HYDROCHLOROTHIAZIDE 163 156 20 11
VESICARE 162 141 21 133
PANTOPRAZOLE SODIUM 157 149 22 37
ESCITALOPRAM OXALATE 147 140 23 68
ALENDRONATE SODIUM 139 110 24 24
NEXIUM 130 85 25 30
TAMSULOSIN HCL 123 114 26 28
NAMENDA 123 122 26 31
CRESTOR 123 114 26 34
TRAMADOL HCL 121 94 29 18
CARBIDOPA-LEVODOPA 120 119 30 71
METFORMIN HCL 119 88 31 8
SPIRONOLACTONE 118 103 32 49
LIDODERM 116 113 33 147
SYNTHROID 113 105 34 50
ATENOLOL 112 97 35 16
MIRTAZAPINE 110 99 36 43
CIPROFLOXACIN HCL 110 98 36 57
LANTUS 109 102 38 39
METOPROLOL SUCCINATE 109 100 38 17
ZOLPIDEM TARTRATE 108 80 40 20
TRAZODONE HCL 102 79 41 48
DIOVAN 101 84 42 63
FENOFIBRATE 100 83 43 77
CLOPIDOGREL 100 90 43 44
NIASPAN 98 65 45 132
OXYCONTIN 94 65 S2 46 126
NYSTATIN 94 91 46 149
LEVOFLOXACIN 93 80 48 84
SEROQUEL 88 73 49 150
FLUTICASONE PROPIONATE 87 87 50 35
LOSARTAN POTASSIUM 87 87 50 19
NOVOLOG 87 87 50 82
DIGOXIN 83 83 53 32
RAMIPRIL 81 67 54 114
ISOSORBIDE MONONITRATE ER 80 80 55 85
PHENADOZ 80 75 10 55 317
BACLOFEN 79 65 57 123
LYRICA 78 49 58 118
CARBAMAZEPINE 75 38 59 165
NITROGLYCERIN PATCH 75 62 59 173
BISOPROLOL FUMARATE 74 74 61 220
LAMOTRIGINE 73 43 62 175
OXYCODONE HCL 67 32 S2 63 79
LANSOPRAZOLE 66 57 64 155
CYCLOBENZAPRINE HCL 65 25 R 65 42
PLAVIX 64 57 66 78
ALLOPURINOL 64 64 66 29
MELOXICAM 63 47 68 23
NAPROXEN 62 36 69 94
ACETAMINOPHEN-CODEINE 61 55 S3 70 134
PAROXETINE HCL 61 61 70 66
GLYBURIDE 61 45 R 70 59
OXYBUTYNIN CHLORIDE 61 53 70 92
TRIAMCINOLONE ACETONIDE 59 51 74 120
NITROFURANTOIN MONO-MACRO 58 55 75 185
MORPHINE SULFATE ER 57 37 S2 76 74
AZITHROMYCIN 56 36 77 47
RANITIDINE HCL 56 55 77 45
PREDNISONE 56 52 77 33
RISPERIDONE 53 40 80 65
OLANZAPINE 52 45 81 122
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 44 81 76
ENABLEX 52 52 81 174
PROAIR HFA 51 31 84 54
ZETIA 51 44 84 81
PRAMIPEXOLE DIHYDROCHLORIDE 51 42 84 152
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 29, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.